Wednesday, November 14, 2018 - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: CSE: $PVOT.C, CSE: $VGW.C, TSX: $WEED.TO, NYSE: $CGC, CSE: $THC.C - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: CSE: $PVOT.C, CSE: $VGW.C, TSX: $WEED.TO, NYSE: $CGC, CSE: $THC.C

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: CSE: $PVOT.C, CSE: $VGW.C, TSX: $WEED.TO, NYSE: $CGC, CSE: $THC.C

Investor Ideas Potcasts Reporting from MJBizCon - CLS Holdings USA, Inc. (OTCQB: $CLSH) Showcasing at MJBizCon

Delta, Kelowna, BC - November 14, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Cannabis Life Sciences a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries will be showcasing at MJBizCon this week in Las Vegas from November 14-16th.
Day one - at MJBizCon this week at Podcast Row interviewing industry leaders and experts.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: CSE: $PVOT.C, CSE: $VGW.C, TSX: $WEED.TO, NYSE: $CGC, CSE: $THC.C

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts. This podcast is sponsored by CLS Holdings USA, Inc. (OTCQB: CLSH).
Today we will be looking at announcements from Pivot Pharmaceuticals Inc. (CSE: PVOT)(OTCQB: PVOTF), Valens GroWorks Corp. (CSE: VGW) (OTCQB: MYMSF), Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and THC BioMed Intl Ltd. (CSE: THC).
Pivot Pharmaceuticals Inc. announced that it has placed a Purchase Order with its German manufacturing partner, Solmic GmbH, for 15,000 bottles of Pivot Naturals Oral 1% CBD Solution. The product will be distributed in the European Union to over 1,800 retail and online clients by Pivot's distribution partner, S.T.U. GmbH. The 30 ml bottle will retail for CHF(Swiss Francs) 90.00 and be available for purchase in December 2018. The product is registered in Germany and has the required Pharmazentralnummer (PZN) code. Once a product is introduced in the IFA database, a Pharmazentralnummer (PZN) is assigned. It is the national standard identification code for products in the pharmacy market in Germany and makes the products eligible for sale in other EU countries.
Dr. Patrick Frankham, Pivot's CEO, stated, "With this initial Purchase Order from Europe, Pivot has completed another important milestone. In one year, the Company has successfully transitioned from acquiring patented formulation and delivery technologies to commercializing our catalogue of differentiated bio-cannabis products and initiating sales. Cannabis is an entirely new market and we are paving the way for premium science-based products consumers will demand. With recently announced sales channels and joint venture partners in Latin America, Europe and Canada, across pharmaceutical and beverage markets, Pivot is well positioned to rapidly capture global market share in the emerging industry."
Valens GroWorks Corp., a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing announced that it has entered into a multi-year Extraction Services Agreement with Harvest One (TSXV:HVT) for cannabis extraction and value-added services.
Under the terms of the Agreement, Harvest One's subsidiary, United Greeneries, will ship bulk quantities of dried cannabis to Valens over an initial three-year term. The Company will receive and process the cannabis on a fee for service basis into bulk resin or other cannabis oil derivative products.
The Company will also conduct R&D services for Harvest One to support their product line development including health and wellness products, beverages, vape pens, and nutraceuticals using cannabis oil derivative products. The significance of these products is reflected in the more developed markets in the United States where raw flower makes up less than half of the products sold.
Canopy Growth Corporation today released its consolidated financial results for the second quarter fiscal 2019 ended September 30, 2018.
During the quarter, Canopy Growth secured capital via a strategic $5 billion investment from Fortune 500 beverage leader Constellation Brands, which closed subsequent to the quarter. These funds will be deployed towards the Company's core strategic objectives of (i) intellectual property development, and (ii) replicating the Company's Canadian platform for success across a large number of international markets. These objectives will be achieved through international acquisitions as well as continued internal investments across the globe, and are discussed in further detail below.
Sales in the second quarter were in line with management's expectations leading into the opening of the recreational cannabis market. Revenue for the second quarter fiscal 2019 was $23.3 million, representing an increase of 33% over the prior year's quarter in which revenue was $17.6 million. As planned, the Company made only limited "test" shipments of $0.7 million into recreational channels during the second quarter to confirm supply chain systems functionality before the launch of recreational cannabis on October 17.  
Oils, including the Company's Softgel capsules, accounted for 34% and 18%, in the respective second quarters of fiscal 2019 and 2018, of the product revenue for each period, demonstrating an increased demand for value-added products that require lower active ingredient inputs and provide higher margins.
"With extensive investments over the past year, including most notably in the second quarter, in branding and retail development, our entrance into the retail cannabis market has been a success with our SKU assortment obtaining over 30% listings market share in multi-store physical retail store networks nationwide. With substantial product inventories on hand, new product formats coming to market as planned, a captive sales force driving increased demand through physical retail stores and increasing internal and channel efficiencies, we believe based on market conditions today that we will attain significant and sustainable market share of the Canadian recreational market," Bruce Linton, Chairman & Co-CEO, Canopy Growth.
THC BioMed Intl Ltd. announced that it has received a Cannabis Act and Cannabis Regulations License from Health Canada on November 8, 2018. This is the new license under the Cannabis Act and it allows THC to grow, produce and sell cannabis products on a large scale under the new regime.
THC also announced that Clone Shipper, its wholly-owned subsidiary, has received a Notice of Allowance from the U.S. Patent and Trademark Office regarding THC's patent application for the invention of an illuminated shipping container for live cannabis plants. THC now has three months to conduct a final review of its patent application, file any necessary amendments, submit the formal drawings and pay the Issue fee. The Notice of Allowance is not a grant of patent rights but a notice from the Examiner that the Application is being allowed.
In addition, due to the high demand for our cannabis products, THC has completed its fourth (4th) shipment of cannabis products to the Province of B.C. Its previous three shipments have sold out since launch day on October 17, 2018.
THC is focused on meeting the high demand for its products. It continues to expand and develop its production space, as announced in previous press releases on October 16, 2018, June 29, 2018, June 12, 2018 and earlier.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit:
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more podcasts visit:
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: Learn more about Investor ideas podcast and news publication services and costs
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.
Please read privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media

No comments:

Post a Comment